Tag Archives: House Energy and Commerce Committee

Drug Shortages Continue to Plague Health Care System

Despite notable successes in preventing and mitigating short supplies of important medicines, the drug shortage crisis still disrupts medical treatment and gives drug manufacturers a bad name. The Food and Drug Administration is doing a better job of identifying potential shortage situations and implementing relief strategies, but many supply problems continue to limit treatment options […]
Posted in FDA, Legal, Manufacturing, Safety, Supply Chain | Also tagged , , , , , | Leave a comment

FDA Already Knew of Problems at New England Compounding Center

By Amy Ritter. In the wake of the meningitis outbreak caused by contaminated compounded medications produced by the New England Compounding Center (NECC), both the government and the public have been wrestling with the question of how this happened — how did a company producing substandard medicines slip through regulatory oversight?
Posted in Guest Blog, Regulatory | Also tagged , , | Leave a comment
  • Categories

  • Meta